Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARWR [NASD]
Arrowhead Research Corp.
Index- P/E- EPS (ttm)-1.96 Insider Own19.02% Shs Outstand31.32M Perf Week-4.80%
Market Cap68.28M Forward P/E- EPS next Y-0.57 Insider Trans- Shs Float28.70M Perf Month21.79%
Income-23.25M PEG- EPS next Q- Inst Own4.04% Short Float2.82% Perf Quarter6.86%
Sales0.28M P/S243.85 EPS this Y-61.86% Inst Trans2.43% Short Ratio6.29 Perf Half Y0.00%
Book/sh0.31 P/B7.03 EPS next Y26.00% ROA-126.42% Target Price4.00 Perf Year-48.46%
Cash/sh0.10 P/C22.84 EPS next 5Y- ROE-184.97% 52W Range1.65 - 4.50 Perf YTD1.87%
Dividend- P/FCF- EPS past 5Y0.00% ROI-167.24% 52W High-51.56% Beta1.81
Dividend %- Quick Ratio- Sales past 5Y-34.39% Gross Margin- 52W Low32.12% ATR0.14
Employees- Current Ratio1.00 Sales Q/Q563.69% Oper. Margin-8336.16% RSI (14)53.13 Volatility6.24% 7.37%
OptionableNo Debt/Eq0.27 EPS Q/Q-33.14% Profit Margin-8585.08% Rel Volume0.33 Prev Close2.21
ShortableYes LT Debt/Eq0.14 EarningsMay 09 Payout- Avg Volume128.69K Price2.18
Recom- SMA204.51% SMA505.22% SMA200-5.01% Volume42,254 Change-1.36%
26-Feb-13Initiated Dawson James Buy $4
17-May-13 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials +5.48%
13-May-13 07:30AM  Arrowhead to Present at Upcoming Scientific Conferences Business Wire
09-May-13 09:45PM  Arrowhead Research's CEO Discusses F2Q13 Results - Earnings Call Transcript at Seeking Alpha
04:01PM  Arrowhead Reports Fiscal 2013 Second Quarter Financial Results Business Wire
09:07AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
07:07AM  Q2 2013 ARROWHEAD RESH CORP Earnings Release - Time Not Supplied CCBN
07-May-13 07:33AM  InPlay: Arrowhead Research receives patent allowance for DPC siRNA Delivery System with peptide backbone Briefing.com +6.97%
07:30AM  Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone Business Wire
06-May-13 07:30AM  Arrowhead Closes $36 Million Private Offering Business Wire
02-May-13 07:00AM  Arrowhead to Report Fiscal 2013 Second Quarter Financial Results Business Wire
30-Apr-13 11:14PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or EDGAR Online +13.19%
02:55PM  5 Health Care Stocks Under $10 to Watch at TheStreet
29-Apr-13 05:01PM  InPlay: Arrowhead prices $36 mln private offering at $1.83 Briefing.com
05:01PM  Arrowhead Prices $36 Million Private Offering Business Wire
24-Apr-13 04:01PM  Arrowhead to Present at Needham Healthcare Conference Business Wire -5.59%
04:01PM  Arrowhead to Present at Master Investor 2013 Business Wire
25-Mar-13 10:22AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
07:12AM  ArrowHead Research indicates 90% reduction in Hepatitis B antigens theflyonthewall.com
07:02AM  InPlay: Arrowhead Research induces 90% reduction in hepatitis B antigens in chimpanzee with chronic infection: data follow previous report of reduction in viral DNA Briefing.com
07:00AM  Arrowhead Induces 90% Reduction in Hepatitis B Antigens in Chimpanzee with Chronic Infection: Data Follow Previous Report of Reduction in Viral DNA Business Wire
14-Mar-13 08:03AM  InPlay: Arrowhead Research RNAi candidate ARC-520 induces greater than 90% reduction in circulating HBV DNA in chimpanzee with chronic Hepatitis B Briefing.com -9.92%
07:15AM  ArrowHead Research RNAi candidate reduces hepatitis B DNA in chimpanzee theflyonthewall.com
07:00AM  Arrowhead RNAi Candidate ARC-520 Induces Greater than 90% Reduction in Circulating HBV DNA in Chimpanzee with Chronic Hepatitis B Business Wire
07-Mar-13 07:00AM  Arrowhead to Host Analyst Event in New York to Discuss RNAi-based Hepatitis B Candidate ARC-520 Business Wire
28-Feb-13 07:02AM  InPlay: Arrowhead Research receives notice of patent allowance for new protease sensitive masking chemistry for DPC siRNA Delivery System Briefing.com
07:00AM  Arrowhead Receives Notice of Patent Allowance for New Protease Sensitive Masking Chemistry for DPC siRNA Delivery System Business Wire
27-Feb-13 06:02PM  Nasdaq stocks posting largest volume increases AP
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwired
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire
26-Feb-13 06:15PM  Nasdaq stocks posting largest volume increases AP
09:09AM  InPlay: Arrowhead Research demonstrates RNAi candidate ARC-520 silences Hepatitis B Virus; Single injection induces multi-log repression of viral RNA, proteins, and viral DNA Briefing.com
09:00AM  Arrowhead Data Demonstrates RNAi Candidate ARC-520 Silences Hepatitis B Virus Business Wire
05:30AM  Coverage initiated on Arrowhead Research by Dawson James Briefing.com
21-Feb-13 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
08:01AM  4 Biotech Stocks Under $10 Moving Higher at TheStreet
14-Feb-13 09:17AM  New Star Analyst Rankings for Arrowhead Research Corporation StarMine
13-Feb-13 10:35PM  Arrowhead Research's CEO Discusses F1Q 2013 Results - Earnings Call Transcript at Seeking Alpha
04:17PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:11PM  ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Arrowhead Reports Fiscal 2013 First Quarter Financial Results Business Wire
07:07AM  Q1 2013 ARROWHEAD RESH CORP Earnings Release - After Market Close CCBN
07-Feb-13 05:26PM  Lifshitz Law Firm Announces Investigation of Arrowhead Research Corp., MEI Pharma, Inc., Park City Group, Inc., and The Toro Company PR Newswire
06-Feb-13 07:00AM  Arrowhead to Report Fiscal 2013 First Quarter Financial Results Business Wire
01-Feb-13 07:00AM  Arrowhead to Present at Upcoming Scientific Conferences Business Wire
30-Jan-13 04:11PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
25-Jan-13 09:35AM  InPlay: Arrowhead Research prices public offering of ~ 1.65 mln units at $2.12 per unit Briefing.com -7.01%
09:34AM  Arrowhead Announces Pricing of a Public Offering of Common Stock and Warrants Business Wire
24-Jan-13 04:13PM  InPlay: Arrowhead Research announces proposed public offering of common stock and warrants Briefing.com
04:13PM  Arrowhead Research Corporation Announces Proposed Public Offering of Common Stock and Warrants Business Wire
03-Jan-13 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
28-Dec-12 12:50PM  ARROWHEAD RESEARCH CORP Files SEC form 10-K, Annual Report EDGAR Online
20-Dec-12 08:10PM  Arrowhead Research Corporation's CEO Discusses F4Q2012 Results - Earnings Call Transcript at Seeking Alpha
04:05PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:02PM  InPlay: Arrowhead Research reports Q4 EPS of ($0.43) Briefing.com
04:01PM  Arrowhead Reports Fiscal 2012 Fourth Quarter and Year-End Financial Results Business Wire
07:07AM  Q4 2012 ARROWHEAD RESH CORP Earnings Release - After Market Close CCBN
19-Dec-12 06:04PM  Nasdaq stocks posting largest volume increases AP
18-Dec-12 06:04PM  Nasdaq stocks posting largest volume increases AP -9.60%
04:32PM  Amgen To Plead Guilty, Arrowhead Partners with Shire: Healthcare Business Recap at Wall St. Cheat Sheet
07:47AM  InPlay from Briefing.com Briefing.com
07:13AM  InPlay from Briefing.com Briefing.com
07:01AM  InPlay: Arrowhead Research and Shire (SHPG) enter into collaboration and license agreement to develop peptide-targeted therapeutics Briefing.com
07:00AM  Arrowhead and Shire Enter into Collaboration and License Agreement to Develop Peptide-Targeted Therapeutics Business Wire
14-Dec-12 07:00AM  Arrowhead to Report Fiscal 2012 Fourth Quarter and Year-End Financial Results Business Wire
12-Dec-12 04:03PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07-Dec-12 09:41AM  InPlay from Briefing.com Briefing.com
09:27AM  InPlay: Arrowhead Research prices public offering of ~ 1.8 mln units at $2.26 per unit Briefing.com
09:25AM  Arrowhead Announces Pricing of a Public Offering of Common Stock and Warrants Business Wire
06-Dec-12 04:33PM  InPlay: Arrowhead Research announces proposed public offering of common stock and warrants Briefing.com
04:32PM  Arrowhead Research Corporation Announces Proposed Public Offering of Common Stock and Warrants Business Wire
03-Dec-12 11:43AM  3 Stocks for the Coming Robot Apocalypse at Motley Fool
27-Nov-12 07:08AM  ArrowHead Research publishes results regarding company's Dynamic Polyconjugate theflyonthewall.com
07:04AM  InPlay: Arrowhead research publishes cholesterol-siRNA mediated gene knockdown in primates and novel DPC co-injection strategy Briefing.com
07:00AM  Arrowhead Publishes First Ever Cholesterol-siRNA Mediated Gene Knockdown in Primates and Novel DPC Co-Injection Strategy Business Wire
13-Nov-12 07:00AM  Arrowhead Creates Hepatitis B Clinical Advisory Board and Names Dr. Robert Gish Chairman Business Wire
12-Nov-12 07:00AM  Arrowhead Research to Present at BIO-Europe 2012 Business Wire
01-Nov-12 01:53PM  5 Stocks Under $10 Set to Trade Higher In November at TheStreet
01:53PM  5 Stocks Under $10 Set to Trade Higher in November at TheStreet
29-Oct-12 07:03AM  InPlay: Arrowhead Research presents data showing 99% target knockdown in monkeys without toxicity using subcutaneous formulation of dynamic polyconjugate siRNA delivery system Briefing.com
07:00AM  Arrowhead Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System Business Wire
16-Oct-12 07:00AM  Arrowhead Research Receives Notice of Patent Allowance for New Formulation of DPC siRNA Delivery System Showing 500-Fold Increase in Potency Business Wire
05-Sep-12 07:00AM  Arrowhead to Present at Rodman and Renshaw Annual Global Investment Conference Business Wire
30-Aug-12 07:06AM  ArrowHead Research completes enrollment in cancer candidate Phase 1b trial at theflyonthewall.com
07:00AM  Arrowhead Completes Enrollment in Phase 1b Trial of RNAi Drug Candidate CALAA-01 Business Wire
21-Aug-12 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
14-Aug-12 09:00PM  Arrowhead's Management Presents at 2012 Wedbush PacGrow Life Sciences Management Access Conference (Transcript) at Seeking Alpha
08:34AM  Arrowhead Research INITIATES Securities Purchase Agreement and 1 Stock Falling to 52-Week Lows at Wall St. Cheat Sheet
07:01AM  InPlay: Arrowhead Research enters into antibody candidate evaluation agreement with Merck (MRK) Briefing.com
07:00AM  Arrowhead Enters into Antibody Candidate Evaluation Agreement with Merck Business Wire
13-Aug-12 08:29PM  Arrowhead Research Corporation's CEO Discusses F3Q12 Results - Earnings Call Transcript at Seeking Alpha -14.15%
05:49PM  Market Recap: Gold Falls, Apples Big Announcement, Google Slashes Jobs at Wall St. Cheat Sheet
04:45PM  Health Care Sector Wrap at Fox Business
04:07PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:05PM  InPlay: Arrowhead Research reported Q3 loss of ($0.71) vs a loss of ($0.25); co reported revs of $47,917 (No revs were reported in last year's quarter) Briefing.com
04:01PM  Arrowhead Reports Fiscal 2012 Third Quarter Financial Results Business Wire
01:28PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:16AM  InPlay: Arrowhead Research raises $6.2 mln through registered direct offering of common stock and warrants Briefing.com
09:15AM  Arrowhead Raises $6.2 Million Through Registered Direct Offering of Common Stock and Warrants Business Wire
07:07AM  Q3 2012 ARROWHEAD RESH CORP Earnings Release - After Market Close CCBN
09-Aug-12 09:00AM  Arrowhead Research to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference Business Wire -8.82%
Arrowhead Research Corporation operates as a clinical stage therapeutics company. It has development programs in oncology, obesity, and chronic hepatitis B virus (HBV) infection. The company assembles a set of technologies, including Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown in rodents and non-human primates, and induces endosomal escape; and RONDEL, a RNA delivery system for systemic siRNA delivery, and RNAi-mediated mRNA and protein knockdown in human melanoma patients. It also offers Homing Peptides platform, a library of short peptides for the development of peptide-drug conjugates and companion diagnostics. The company's principal product candidates include Adipotide, an anti-obesity peptide, which is in Phase I clinical trial for disrupting the blood supply that supports unhealthy fat by the targeted induction of apoptosis (cell death) in the vasculature of adipose tissue; ARC-520, an RNAi-based therapeutic to treat chronic HBV infection; and CALAA-01, an RNAi-based therapeutic that has completed a Phase IB clinical trial, which targets solid tumors. Its products also comprise CRLX-101 for NSC lung cancer; and Tubulin Inhibitor for oncology. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.